Insider Trading activities of Synergy Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synergy Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Synergy Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Synergy Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is SGYP. The reporting company's CIK number is 1347613.
The total value of stock buying since 2005 is $1,756,134.
The total value of stock sales since 2005 is $45,355,574.
The total value of stock option exercises since 2005 is $452,753.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Synergy Pharmaceuticals, Inc. (SGYP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 8,750,000 $24,675,000 0 $0
2017-08 0 $0 26,287 $99,180 0 $0
2017-05 12,180 $43,300 0 $0 0 $0
2016-11 0 $0 140,000 $593,880 0 $0
2016-09 0 $0 3,530,531 $19,813,073 2,518 $11,192
2015-09 0 $0 23,754 $174,441 23,754 $88,328
2015-07 0 $0 0 $0 62,965 $353,233
2014-06 3,500 $14,420 0 $0 0 $0
2014-05 9,500 $38,115 0 $0 0 $0
2013-10 12,000 $49,080 0 $0 0 $0
2013-06 15,500 $71,210 0 $0 0 $0
2013-04 23,500 $106,976 0 $0 0 $0
2013-02 19,090 $115,829 0 $0 0 $0
2012-11 87,820 $317,205 0 $0 0 $0
2011-11 470,588 $999,999 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Synergy Pharmaceuticals, Inc. insiders (SGYP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-10 Paulson & Co. Inc. Sale 8,750,000 2.82 24,675,000
2017-08-07 Paulson & Co. Inc. Sale 26,287 3.77 99,180
2017-05-26 Brancaccio John P (Director) Buy 6,500 3.59 23,335
2017-05-26 Jacob Gary S (Chief Executive Officer) Buy 5,680 3.52 19,965
2016-11-04 Paulson & Co. Inc. Sale 140,000 4.24 593,880
2016-09-28 Paulson & Co. Inc. Sale 20,700 5.60 116,002
2016-09-27 Paulson & Co. Inc. Sale 33,600 5.75 193,065
2016-09-19 Brancaccio John P (Director) Sale 2,518 5.76 14,503
2016-09-19 Brancaccio John P (Director) Option Ex 2,518 4.45 11,192
2016-09-19 Paulson & Co. Inc. Sale 1,500,000 5.61 8,415,000
2016-09-16 Paulson & Co. Inc. Sale 1,973,713 5.61 11,074,503
2015-09-14 Denoyer Bernard (Senior Vice President, Finance) Sale 10,000 7.50 75,000
2015-09-14 Denoyer Bernard (Senior Vice President, Finance) Option Ex 10,000 3.40 34,000
2015-09-11 Joslyn Alan (Director) Sale 13,754 7.23 99,441
2015-09-11 Joslyn Alan (Director) Option Ex 13,754 3.95 54,328
2015-07-01 Jacob Gary S (Chief Executive Officer) Option Ex 62,965 5.61 353,233
2014-06-03 Brancaccio John P (Director) Buy 3,500 4.12 14,420
2014-05-27 Jacob Gary S (Chief Executive Officer) Buy 4,000 4.18 16,720
2014-05-23 Denoyer Bernard (Senior Vice President, Finance) Buy 2,500 3.89 9,725
2014-05-23 Shailubhai Kunwar (Chief Scientific Officer) Buy 3,000 3.89 11,670
2013-10-29 Cerrone Gabriel (Other) Buy 12,000 4.09 49,080
2013-06-21 Denoyer Bernard (Senior Vice President, Finance) Buy 7,500 4.78 35,850
2013-06-14 Cerrone Gabriel (Chairman) Buy 8,000 4.42 35,360
2013-04-24 Cerrone Gabriel (Chairman) Buy 18,000 4.56 81,363
2013-02-05 Cerrone Gabriel (Chairman) Buy 4,000 6.18 24,712
2013-02-04 Cerrone Gabriel (Chairman) Buy 14,090 6.04 85,077
2012-11-14 Cerrone Gabriel (Chairman) Buy 87,820 3.61 317,205
2011-11-14 Cerrone Gabriel (Chairman) Buy 470,588 2.12 999,999

Insider trading activities including stock purchases, stock sales, and option exercises of SGYP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synergy Pharmaceuticals, Inc. (symbol SGYP, CIK number 1347613) see the Securities and Exchange Commission (SEC) website.